Literature DB >> 7511454

A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.

S Chen1, P S Deng, J M Bailey, K M Swiderek.   

Abstract

NAD(P)H:quinone acceptor oxidoreductase (EC 1.6.99.2) (DT-diaphorase) is a FAD-containing reductase that catalyzes a unique 2-electron reduction of quinones. It consists of 2 identical subunits. In this study, it was found that the carboxyl-terminal portion of the 2 subunits can be cleaved by various proteases, whereas the amino-terminal portion cannot. It was also found that proteolytic digestion of the enzyme can be blocked by the prosthetic group FAD, substrates NAD(P)H and menadione, and inhibitors dicoumarol and phenindione. Interestingly, chrysin and Cibacron blue, 2 additional inhibitors, cannot protect the enzyme from proteolytic digestion. The results obtained from this study indicate that the subunit of the quinone reductase has a 2-domain structure, i.e., an amino-terminal compact domain and a carboxyl-terminal flexible domain. A structural model of the quinone reductase is generated based on results obtained from amino-terminal and carboxyl-terminal protein sequence analyses and electrospray mass spectral analyses of hydrolytic products of the enzyme generated by trypsin, chymotrypsin, and Staphylococcus aureus protease. Furthermore, based on the data, it is suggested that the binding of substrates involves an interaction between 2 structural domains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511454      PMCID: PMC2142469          DOI: 10.1002/pro.5560030107

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties.

Authors:  L ERNSTER; L DANIELSON; M LJUNGGREN
Journal:  Biochim Biophys Acta       Date:  1962-04-09

2.  Preliminary crystallographic data for NAD(P)H quinone reductase isolated from the Walker 256 rat carcinoma cell line.

Authors:  J V Skelly; D A Suter; R J Knox; E Garman; D I Stuart; M R Sanderson; J J Roberts; S Neidle
Journal:  J Mol Biol       Date:  1989-02-05       Impact factor: 5.469

3.  Inhibition of rat liver NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by flavonoids isolated from the Chinese herb scutellariae radix (Huang Qin).

Authors:  X F Liu; M L Liu; T Iyanagi; K Legesse; T D Lee; S A Chen
Journal:  Mol Pharmacol       Date:  1990-06       Impact factor: 4.436

4.  Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.

Authors:  A K Jaiswal; P Burnett; M Adesnik; O W McBride
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

5.  Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.

Authors:  D Siegel; N W Gibson; P C Preusch; D Ross
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

6.  Rat liver NAD(P)H: quinone reductase nucleotide sequence analysis of a quinone reductase cDNA clone and prediction of the amino acid sequence of the corresponding protein.

Authors:  R M Bayney; J A Rodkey; C D Bennett; A Y Lu; C B Pickett
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

7.  Rat liver NAD(P)H:quinone oxidoreductase: cDNA expression and site-directed mutagenesis.

Authors:  G L Forrest; J Qian; J X Ma; W D Kaplan; S Akman; J Doroshow; S A Chen
Journal:  Biochem Biophys Res Commun       Date:  1990-06-29       Impact factor: 3.575

8.  X-ray diffraction analyses of crystals of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase containing cibacron blue.

Authors:  X Ysern; H J Prochaska
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

9.  Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.

Authors:  X F Liu; H Yuan; M Haniu; T Iyanagi; J E Shively; S A Chen
Journal:  Mol Pharmacol       Date:  1989-06       Impact factor: 4.436

10.  Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.

Authors:  H J Prochaska
Journal:  Arch Biochem Biophys       Date:  1988-12       Impact factor: 4.013

View more
  14 in total

1.  Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

Authors:  Q Zhao; X L Yang; W D Holtzclaw; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 2.  Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1.

Authors:  Eduardo Salido; David J Timson; Isabel Betancor-Fernández; Rogelio Palomino-Morales; Ernesto Anoz-Carbonell; Juan Luis Pacheco-García; Milagros Medina; Angel L Pey
Journal:  J Pers Med       Date:  2022-05-05

Review 3.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

4.  The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.

Authors:  R Li; M A Bianchet; P Talalay; L M Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

5.  Redox modulation of NQO1.

Authors:  David Siegel; Donna D Dehn; Samantha S Bokatzian; Kevin Quinn; Donald S Backos; Andrea Di Francesco; Michel Bernier; Nichole Reisdorph; Rafael de Cabo; David Ross
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.752

6.  Oxidative stress-induced structural changes in the microtubule-associated flavoenzyme Irc15p from Saccharomyces cerevisiae.

Authors:  Karin Koch; Emilia Strandback; Shalinee Jha; Gesa Richter; Benjamin Bourgeois; Tobias Madl; Peter Macheroux
Journal:  Protein Sci       Date:  2019-01       Impact factor: 6.725

7.  Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1).

Authors:  Wolf-Dieter Lienhart; Emilia Strandback; Venugopal Gudipati; Karin Koch; Alexandra Binter; Michael K Uhl; David M Rantasa; Benjamin Bourgeois; Tobias Madl; Klaus Zangger; Karl Gruber; Peter Macheroux
Journal:  FEBS J       Date:  2017-03-17       Impact factor: 5.542

8.  A small molecule chaperone rescues the stability and activity of a cancer-associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro.

Authors:  Emilia Strandback; Wolf-Dieter Lienhart; Altijana Hromic-Jahjefendic; Benjamin Bourgeois; Anja Högler; Daniel Waltenstorfer; Andreas Winkler; Klaus Zangger; Tobias Madl; Karl Gruber; Peter Macheroux
Journal:  FEBS Lett       Date:  2019-10-30       Impact factor: 4.124

9.  Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands.

Authors:  Encarnación Medina-Carmona; Rogelio J Palomino-Morales; Julian E Fuchs; Esperanza Padín-Gonzalez; Noel Mesa-Torres; Eduardo Salido; David J Timson; Angel L Pey
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

Review 10.  Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch.

Authors:  David Ross; David Siegel
Journal:  Front Physiol       Date:  2017-08-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.